No Clear Winner in C. Difficile Battle (CME/CE)
(MedPage Today) — No antibiotic has proven to be consistently superior as a first-shot cure for Clostridium difficile infection, although the recently approved macrycyclic agent fidaxomicin (Dificid) was associated with fewer recurrences, a systematic review showed.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com